Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany

Clinical Microbiology and Infection

Volumn 16, Issue 6, 2010, Pages 613-616

  Dumke, R ^a   von Baum, H ^b   Luck P C ^a   Jacobs, E ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

23S rRNA; Community acquired pneumonia; Macrolide resistance; Mycoplasma pneumoniae; Real time PCR

Indexed keywords

ERYTHROMYCIN; MACROLIDE; RNA 23S;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; GERMANY; HUMAN; LUNG LAVAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPUTUM CULTURE; THROAT CULTURE;

MYCOPLASMA PNEUMONIAE;

EID: 77953919333     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02968.x     Document Type: Article

References (16)

1. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008, 32:956-973.
2. Bebear CM, Pereyre S. Mechanisms of drug resistance in Mycoplasma pneumoniae. Curr Drug Targets Infect Disord 2005, 5:263-271.
3. Pereyre S, Guyot C, Renaudin H, Charron A, Bebear C, Bebear CM. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob Agents Chemother 2004, 48:460-465.
4. Matsuoka M, Narita M, Okazaki N. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother 2004, 48:4624-4630.
5. Morozumi M, Iwata S, Hasegawa K. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother 2008, 52:348-350. Acute respiratory diseases study group
6. Xin D, Mi Z, Han X. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother 2009, 53:2158-2159.
7. Liu Y, Ye X, Zhang H. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis on macrolide-resistant strains from Shanghai, China. Antimicrob Agents Chemother 2009, 53:2160-2162.
8. Pereyre S, Charron A, Renaudin H, Bebear C, Bebear CM. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol 2007, 45:3534-3539.
9. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother 2008, 52:3542-3549.
10. Dumke R, Lück PC, Schaefer C. Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples. J Clin Microbiol 2006, 44:2567-2570.
11. Dumke R, Catrein I, Pirkl E, Herrmann R, Jacobs E. Subtyping of Mycoplasma pneumoniae isolates based on extended genome sequencing and on expression profiles. Int J Med Microbiol 2003, 292:513-525.
12. Dumke R, Schurwanz N, Lenz M, Schuppler M, Lück C, Jacobs E. Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach. J Clin Microbiol 2007, 45:2726-2730.
13. Waites KB, Bebear CM, Robertson JA, Talkington DF, Kenny GE. Cumitech 34, Laboratory diagnosis of mycoplasmal infections eds, American Society for Microbiology, Washington, DC, 2007
14. Okazaki N, Narita M, Yamada S. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol 2001, 45:617-620.
15. Morozumi M, Hasegawa K, Kobayashi R. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother 2005, 49:2302-2306.
16. Mandell LA, Wunderink RG, Anzueto A. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 15:S27-72.